Daniel Geller

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder
    Daniel Geller
    Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, 185 Alewife Brook Parkway, Cambridge, MA 02138, USA
    J Am Acad Child Adolesc Psychiatry 46:1119-27. 2007
  2. pmc Perinatal factors affecting expression of obsessive compulsive disorder in children and adolescents
    Daniel A Geller
    Clinical and Research Program in Pediatric Psychopharmacology, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02318, USA
    J Child Adolesc Psychopharmacol 18:373-9. 2008
  3. ncbi request reprint Examining the relationship between obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in children and adolescents: a familial risk analysis
    Daniel Geller
    Pediatric Psychopharmacology Program, Center for Human Genetics, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02113, USA
    Biol Psychiatry 61:316-21. 2007
  4. ncbi request reprint Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis
    Daniel Geller
    Pediatric Psychopharmacology Program, Department of Psychiatry, Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetics, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Biol Psychiatry 61:1388-94. 2007
  5. ncbi request reprint Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial
    Daniel A Geller
    Harvard Medical School, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 43:1387-96. 2004
  6. ncbi request reprint Re-examining comorbidity of Obsessive Compulsive and Attention-Deficit Hyperactivity Disorder using an empirically derived taxonomy
    D A Geller
    Pediatric OCD Clinic, Massachusetts General Hospital, WACC 725, 15 Parkman Street, Boston, MA 02114, USA
    Eur Child Adolesc Psychiatry 13:83-91. 2004
  7. ncbi request reprint Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder
    Daniel A Geller
    Pediatric OCD Problem, WACC 725, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 02114, USA
    Am J Psychiatry 160:1919-28. 2003
  8. ncbi request reprint Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
    Daniel A Geller
    Obsessive Compulsive Disorder Program, Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Child Adolesc Psychopharmacol 13:S19-29. 2003
  9. ncbi request reprint A quick and reliable screening measure for OCD in youth: reliability and validity of the obsessive compulsive scale of the Child Behavior Checklist
    Daniel A Geller
    Pediatric Psychopharmacology Clinic, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    Compr Psychiatry 47:234-40. 2006
  10. ncbi request reprint A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder
    Thomas Spencer
    Pediatric Psychopharmacology Unit, Psychiatry Service, Massachusetts General Hospital, Boston, MA 02114, USA
    Arch Gen Psychiatry 59:649-56. 2002

Detail Information

Publications31

  1. ncbi request reprint Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder
    Daniel Geller
    Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, 185 Alewife Brook Parkway, Cambridge, MA 02138, USA
    J Am Acad Child Adolesc Psychiatry 46:1119-27. 2007
    ....
  2. pmc Perinatal factors affecting expression of obsessive compulsive disorder in children and adolescents
    Daniel A Geller
    Clinical and Research Program in Pediatric Psychopharmacology, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02318, USA
    J Child Adolesc Psychopharmacol 18:373-9. 2008
    ..To examine whether adverse perinatal experiences of children are associated with obsessive compulsive disorder (OCD) in youth...
  3. ncbi request reprint Examining the relationship between obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in children and adolescents: a familial risk analysis
    Daniel Geller
    Pediatric Psychopharmacology Program, Center for Human Genetics, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02113, USA
    Biol Psychiatry 61:316-21. 2007
    ..To use family study methodology to examine the relationship between obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD) in children and adolescents...
  4. ncbi request reprint Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis
    Daniel Geller
    Pediatric Psychopharmacology Program, Department of Psychiatry, Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetics, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Biol Psychiatry 61:1388-94. 2007
    ..To examine the relationship between obsessive compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD) in children and adolescents using familial risk analysis...
  5. ncbi request reprint Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial
    Daniel A Geller
    Harvard Medical School, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 43:1387-96. 2004
    ..To assess the efficacy and safety of paroxetine for the treatment of pediatric obsessive-compulsive disorder...
  6. ncbi request reprint Re-examining comorbidity of Obsessive Compulsive and Attention-Deficit Hyperactivity Disorder using an empirically derived taxonomy
    D A Geller
    Pediatric OCD Clinic, Massachusetts General Hospital, WACC 725, 15 Parkman Street, Boston, MA 02114, USA
    Eur Child Adolesc Psychiatry 13:83-91. 2004
    ....
  7. ncbi request reprint Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder
    Daniel A Geller
    Pediatric OCD Problem, WACC 725, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 02114, USA
    Am J Psychiatry 160:1919-28. 2003
    ....
  8. ncbi request reprint Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
    Daniel A Geller
    Obsessive Compulsive Disorder Program, Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Child Adolesc Psychopharmacol 13:S19-29. 2003
    ..To examine the influence of psychiatric comorbidity on response and relapse rates in children and adolescents treated with paroxetine for obsessive-compulsive disorder (OCD)...
  9. ncbi request reprint A quick and reliable screening measure for OCD in youth: reliability and validity of the obsessive compulsive scale of the Child Behavior Checklist
    Daniel A Geller
    Pediatric Psychopharmacology Clinic, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    Compr Psychiatry 47:234-40. 2006
    ....
  10. ncbi request reprint A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder
    Thomas Spencer
    Pediatric Psychopharmacology Unit, Psychiatry Service, Massachusetts General Hospital, Boston, MA 02114, USA
    Arch Gen Psychiatry 59:649-56. 2002
    ..To address this issue, we evaluated the tolerability and efficacy of the noradrenergic tricyclic antidepressant desipramine hydrochloride in the treatment of children and adolescents with chronic tic disorders and comorbid ADHD...
  11. pmc Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents
    Gagan Joshi
    Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    Bipolar Disord 12:185-95. 2010
    ....
  12. doi request reprint Does ADHD moderate the manifestation of anxiety disorders in children?
    Paul Hammerness
    Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA 02138, USA
    Eur Child Adolesc Psychiatry 19:107-12. 2010
    ..ADHD had a limited impact on the manifestation of anxiety disorder in children suggesting that ADHD and anxiety disorders are independently expressed...
  13. doi request reprint Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder
    Gagan Joshi
    Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    Bipolar Disord 12:196-204. 2010
    ..To compare antimanic response to olanzapine therapy in youth with bipolar disorder (BPD) based on the status of comorbidity with obsessive-compulsive disorder (OCD)...
  14. doi request reprint Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate
    Paul Hammerness
    Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02138, USA
    J Pediatr 162:22-7.e2. 2013
    ..Although attention-deficit hyperactivity disorder (ADHD) is a well-known risk factor for cigarette smoking, prospective studies aimed at reducing smoking risk in this population are critically needed...
  15. ncbi request reprint Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents
    S Evelyn Stewart
    Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02114, USA
    Biol Psychiatry 61:285-91. 2007
    ..The purpose of this study was to conduct an exploratory principal components analysis of obsessive-compulsive (OC) symptoms in children and adolescents with OCD to identify improved phenotypes for future studies...
  16. pmc Case series: Sensory intolerance as a primary symptom of pediatric OCD
    Eric P Hazen
    Clinical Research Program in Pediatric Psychopharmacology, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    Ann Clin Psychiatry 20:199-203. 2008
    ..Marked intolerance or intrusive re-experiencing of ordinary sensory stimuli that in turn drive functionally impairing compulsive behaviors are occasionally seen in young children with OCD...
  17. ncbi request reprint Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome
    Thomas J Spencer
    Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA 02114 2696, USA
    J Atten Disord 11:470-81. 2008
    ..This study examines changes in severity of tics and ADHD during atomoxetine treatment in ADHD patients with Tourette syndrome (TS)...
  18. ncbi request reprint Reexamining Tic persistence and Tic-associated impairment in Tourette's Disorder: findings from a naturalistic follow-up study
    Barbara J Coffey
    Joint Program in Pediatric Psychopharmacology of Massachusetts General Hospital and McLean Hospital, Boston, Massachusetts, USA
    J Nerv Ment Dis 192:776-80. 2004
    ..These results support the view that TD is a persistent disorder, but suggest a dissociation between tic persistence and tic-associated dysfunction...
  19. ncbi request reprint Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series
    Robert L Doyle
    Department of Psychiatry, Harvard Medical School, USA
    J Atten Disord 9:543-9. 2006
    ..Because work in dementia documents improvement in executive function deficits with the acetylcholinesterase inhibitor donepezil, the authors reason that similar benefits could be obtained in PDD...
  20. ncbi request reprint Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment
    Thomas J Spencer
    Massachusetts General Hospital Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
    J Child Adolesc Psychopharmacol 17:689-700. 2007
    ..To examine the effects on growth of long-term pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD), we present findings from an ongoing 5-year study of the efficacy and safety of treatment with atomoxetine...
  21. ncbi request reprint A controlled family study of attention-deficit/hyperactivity disorder and Tourette's disorder
    S Evelyn Stewart
    Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA
    J Am Acad Child Adolesc Psychiatry 45:1354-62. 2006
    ..Familial relationships between DSM-IV ADHD and TD are studied in TD+ADHD, TD-only (TD-ADHD), ADHD-only (ADHD-TD), and control groups...
  22. doi request reprint Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults
    S Evelyn Stewart
    Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 47:763-72. 2008
    ..Identification of a category-based OCD symptom dimension structure that is validated for use across child, adolescent, and adult age groups is necessary to guide ongoing translational research...
  23. ncbi request reprint Obsessive-compulsive and spectrum disorders in children and adolescents
    Daniel A Geller
    Pediatric Obsessive Compulsive Disorder Program, Division of Pediatric Psychopharmacology, Massachusetts General Hospital, YAW 6A, Fruit Street, Boston, MA 02114, USA
    Psychiatr Clin North Am 29:353-70. 2006
    ..Often cognitive antecedents to these behaviors are less well developed than in more typical OCD, and behavioral interventions are the mainstay of treatment but with more variable success...
  24. ncbi request reprint Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder?
    Daniel A Geller
    Obsessive Compulsive Disorder Clinical Research Program, Massachusetts General Hospital, Boston 02114, USA
    CNS Spectr 8:259-64. 2003
    ..In such affected youths, both disorders contribute to morbid dysfunction and require treatment. More work is needed to determine whether OCD plus ADHD represents a developmentally and etiologically distinct form of the OCD syndrome...
  25. ncbi request reprint Performance of clinician versus self-report measures to identify obsessive-compulsive disorder in children and adolescents
    S Evelyn Stewart
    Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA
    J Child Adolesc Psychopharmacol 15:956-63. 2005
    ....
  26. ncbi request reprint Dissociation between MEG alpha modulation and performance accuracy on visual working memory task in obsessive compulsive disorder
    Kristina T Ciesielski
    MGH MIT HMS Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
    Hum Brain Mapp 28:1401-14. 2007
    ....
  27. doi request reprint Treatment of pediatric obsessive-compulsive disorder: a review
    Elizabeth Mancuso
    Clinical and Research Program in Pediatric Psychopharmacology, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02138, USA
    J Child Adolesc Psychopharmacol 20:299-308. 2010
    ..The purpose of this article is to review assessment and treatment strategies to include current advances in research...
  28. ncbi request reprint Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence
    Paul G Hammerness
    Department of Psychiatry, Pediatric Psychopharmacology Research Program, Harvard Medical School, Boston, MA, USA
    J Pediatr 148:158-65. 2006
  29. ncbi request reprint Increased MEG activation in OCD reflects a compensatory mechanism specific to the phase of a visual working memory task
    Kristina T Ciesielski
    MGH MIT HMS Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA
    Neuroimage 24:1180-91. 2005
    ..The findings do not support the concept of a faulty working memory mechanism per se in OCD...
  30. ncbi request reprint Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact?
    Daniel A Geller
    Obsessive Compulsive Disorder Clinic, McLean Hospital, Belmont, MA 02478, USA
    J Am Acad Child Adolesc Psychiatry 41:52-8. 2002
    ....
  31. ncbi request reprint The promise and challenge of obsessive-compulsive disorder research
    Daniel A Geller
    Biol Psychiatry 61:263-5. 2007

Research Grants4

  1. JUVENILE ONSET OCD AS A MEANINGFUL DEVELOPMENT SUBTYPE
    Daniel Geller; Fiscal Year: 2003
    ..The clinical, scientific, and public health relevance of confirming or refuting these hypotheses is discussed. ..
  2. Obsessive-compulsive disorder (OCD) Collaborative Genetics Association Study
    Daniel A Geller; Fiscal Year: 2010
    ..The results of these analyses will guide future molecular strategies to identify genes involved in the pathogenesis of OCD. The clinical and genotype data from the sample will be publicly available for OCD genetics research. ..